Don't Be Surprised to See Zelnorm Return to Your Inventory

Zelnorm (tegaserod) will be back on pharmacy shelves to treat irritable bowel syndrome with constipation (IBS-C) in women.

It was taken off the market in 2007...due to reports of heart attack, stroke, and other cardiovascular (CV) problems.

Since then, it's been available on a case-by-case basis from various manufacturers.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote